Nectar Lifesciences Limited Share Price & Analysis
₹11.98 0.00%Updated 5 Jun 2026, 05:02 pm IST
LTP
₹11.98
+0%
Open
₹—
High
₹12.15
Low
₹11.86
Close
₹11.98
52W High
₹25.7
52W Low
₹9.2
Volume
197K
Lot Size
1
Sector
Healthcare
Market Cap
₹231 Cr
Face Value
₹1
Small Cap
Price Chart
Fundamentals
P/E
—
Sector P/E
48.9
P/B
0.41
EPS
₹-2.62
ROE
-7.46%
ROCE
-4.88%
D/E Ratio
0.64
Div Yield
0%
Book Value
₹30
+
Strengths
- ✓Trading below book value (P/B 0.4x)
−
Concerns
- ✗Currently loss-making (EPS ₹-2.6)
- ✗Negative return on equity (ROE -7.5%)
- ✗Negative return on capital (ROCE -4.9%)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,783 | ₹4.3L Cr | 34.4 | 5.12 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹6,616 | ₹1.7L Cr | 66.1 | 10.48 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,416 | ₹1.5L Cr | 66.4 | 17.81 | 27.6 | 15.4 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,315 | ₹1.2L Cr | 59.5 | 12.62 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,402 | ₹1.1L Cr | 27.3 | 3.29 | 12.4 | 16.6 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,091 | ₹1.1L Cr | 20 | 4.05 | 21.2 | 21.2 | 0.38 |
| DRREDDY Dr. Reddy's Laboratories Limited | ₹1,283 | ₹1.1L Cr | 25.4 | 2.83 | 11.8 | 13.6 | 0.16 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
NECLIFE · as of Mar 2026
Promoters44.53%
FII1.65%▲0.92
DII0.15%
Public53.64%▼1.08
Govt0.02%
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 55.80% | 55.80% | 55.80% | 55.80% | 44.53% | 44.53% |
| FII | 16.12% | 16.98% | 16.60% | 3.24% | 0.73% | 1.65% |
| DII | — | — | — | — | — | 0.15% |
| Public | 28.05% | 27.20% | 27.57% | 40.94% | 54.72% | 53.64% |
| Govt | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% |
Corporate Events
Buy Back
Buy Back23 Dec 2025
Annual General Meeting
AGM12 Sept 2024
Annual General Meeting
AGM13 Sept 2023
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹0 Cr ▼100.0% | ₹1 Cr ▼80.0% | ₹5 Cr ▼98.8% | ₹431 Cr | ₹0 Cr ▼100.0% | ₹6 Cr ▼98.3% | ₹359 Cr ▼18.6% | ₹441 Cr |
| Op. Profit | ₹-2 Cr ▼300.0% | ₹1 Cr ▲200.0% | ₹-1 Cr ▲99.4% | ₹-154 Cr | ₹0 Cr ▲100.0% | ₹-1 Cr ▼102.5% | ₹40 Cr ▼16.7% | ₹48 Cr |
| OPM | — | 77.0% ▲581.3% | -16.0% ▲55.6% | -36.0% ▲92.8% | -500.0% ▼4900.0% | -10.0% ▼190.9% | 11.0% ▲0.0% | 11.0% |
| Net Profit | ₹14 Cr ▲108.0% | ₹-176 Cr ▼179.4% | ₹-63 Cr ▲51.5% | ₹-130 Cr ▼1725.0% | ₹8 Cr ▲33.3% | ₹6 Cr ▲100.0% | ₹3 Cr ▲200.0% | ₹1 Cr |
| EPS (₹) | 0.64 ▲108.2% | -7.85 ▼178.4% | -2.82 ▲51.4% | -5.8 ▼1757.1% | 0.35 ▲40.0% | 0.25 ▲92.3% | 0.13 ▲333.3% | 0.03 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1.7K Cr ▼1.1% | ₹1.7K Cr ▲10.7% | ₹1.5K Cr ▼8.7% | ₹1.7K Cr ▲8.0% | ₹1.5K Cr ▼34.8% | ₹2.4K Cr ▼15.0% | ₹2.8K Cr ▲48.3% | ₹1.9K Cr ▲14.6% | ₹1.6K Cr |
| Expenses | ₹1.7K Cr ▲10.7% | ₹1.5K Cr ▲4.3% | ₹1.5K Cr ▼2.7% | ₹1.5K Cr ▲5.2% | ₹1.4K Cr ▼33.2% | ₹2.1K Cr ▼14.8% | ₹2.5K Cr ▲53.5% | ₹1.6K Cr ▲16.1% | ₹1.4K Cr |
| Op. Profit | ₹-30 Cr ▼119.7% | ₹152 Cr ▲186.8% | ₹53 Cr ▼66.7% | ₹159 Cr ▲45.9% | ₹109 Cr ▼50.5% | ₹220 Cr ▼16.7% | ₹264 Cr ▲11.9% | ₹236 Cr ▲5.4% | ₹224 Cr |
| OPM | -2.0% ▼122.2% | 9.0% ▲200.0% | 3.0% ▼70.0% | 10.0% ▲42.9% | 7.0% ▼22.2% | 9.0% ▼10.0% | 10.0% ▼23.1% | 13.0% ▼7.1% | 14.0% |
| Other Income | ₹5 Cr ▼66.7% | ₹15 Cr ▼65.1% | ₹43 Cr ▲290.9% | ₹11 Cr ▲150.0% | ₹-22 Cr ▼650.0% | ₹4 Cr ▼33.3% | ₹6 Cr ▲0.0% | ₹6 Cr ▼73.9% | ₹23 Cr |
| Interest | ₹75 Cr ▼13.8% | ₹87 Cr ▲10.1% | ₹79 Cr ▲0.0% | ₹79 Cr ▼29.5% | ₹112 Cr ▼11.1% | ₹126 Cr ▼14.9% | ₹148 Cr ▲28.7% | ₹115 Cr ▼1.7% | ₹117 Cr |
| Depreciation | ₹62 Cr ▲1.6% | ₹61 Cr ▲3.4% | ₹59 Cr ▲3.5% | ₹57 Cr ▼5.0% | ₹60 Cr ▼1.6% | ₹61 Cr ▼3.2% | ₹63 Cr ▼1.6% | ₹64 Cr ▲3.2% | ₹62 Cr |
| PBT | ₹-162 Cr ▼1000.0% | ₹18 Cr ▲142.9% | ₹-42 Cr ▼223.5% | ₹34 Cr ▲140.0% | ₹-85 Cr ▼329.7% | ₹37 Cr ▼37.3% | ₹59 Cr ▼6.3% | ₹63 Cr ▼6.0% | ₹67 Cr |
| Tax % | -30.0% ▼141.1% | 73.0% ▲269.8% | -43.0% ▼265.4% | 26.0% ▲285.7% | -14.0% ▼193.3% | 15.0% ▼21.1% | 19.0% ▲11.8% | 17.0% ▼5.6% | 18.0% |
| Net Profit | ₹-114 Cr ▼2380.0% | ₹5 Cr ▲120.8% | ₹-24 Cr ▼196.0% | ₹25 Cr ▲134.2% | ₹-73 Cr ▼328.1% | ₹32 Cr ▼33.3% | ₹48 Cr ▼7.7% | ₹52 Cr ▼5.5% | ₹55 Cr |
| EPS (₹) | -5.07 ▼2404.5% | 0.22 ▲120.4% | -1.08 ▼196.4% | 1.12 ▲134.3% | -3.27 ▼330.3% | 1.42 ▼33.0% | 2.12 ▼9.0% | 2.33 ▼5.7% | 2.47 |
| Div Payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% ▼100.0% | 4.0% ▲100.0% | 2.0% ▲0.0% | 2.0% ▲0.0% | 2.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹22 Cr ▲0.0% | ₹22 Cr ▲0.0% | ₹22 Cr ▲0.0% | ₹22 Cr ▲0.0% | ₹22 Cr ▲0.0% | ₹22 Cr ▲0.0% | ₹22 Cr ▲0.0% | ₹22 Cr ▲0.0% | ₹22 Cr ▲0.0% | ₹22 Cr |
| Reserves | ₹694 Cr ▼25.7% | ₹934 Cr ▼10.8% | ₹1.0K Cr ▲0.5% | ₹1.0K Cr ▼2.2% | ₹1.1K Cr ▲2.4% | ₹1.0K Cr ▼6.6% | ₹1.1K Cr ▲2.9% | ₹1.1K Cr ▲4.5% | ₹1.0K Cr ▲5.3% | ₹984 Cr |
| Borrowings | ₹459 Cr ▼21.1% | ₹582 Cr ▼8.5% | ₹636 Cr ▼15.6% | ₹754 Cr ▼12.3% | ₹860 Cr ▼4.8% | ₹903 Cr ▲15.9% | ₹779 Cr ▼13.7% | ₹903 Cr ▼5.4% | ₹955 Cr ▲8.8% | ₹878 Cr |
| Other Liabilities | ₹639 Cr ▲25.5% | ₹509 Cr ▲4.7% | ₹486 Cr ▲31.0% | ₹371 Cr ▼16.3% | ₹443 Cr ▲4.7% | ₹423 Cr ▼41.1% | ₹718 Cr ▲3.2% | ₹696 Cr ▼2.0% | ₹710 Cr ▲2.0% | ₹696 Cr |
| Total Liabilities | ₹1.8K Cr ▼11.3% | ₹2.0K Cr ▼6.6% | ₹2.2K Cr ▲0.1% | ₹2.2K Cr ▼8.4% | ₹2.4K Cr ▲0.1% | ₹2.4K Cr ▼9.3% | ₹2.6K Cr ▼2.7% | ₹2.7K Cr ▼0.7% | ₹2.7K Cr ▲5.5% | ₹2.6K Cr |
| Assets | ||||||||||
| Fixed Assets | ₹28 Cr ▼95.6% | ₹633 Cr ▼1.6% | ₹643 Cr ▼2.9% | ₹662 Cr ▼8.4% | ₹723 Cr ▼6.3% | ₹772 Cr ▼1.7% | ₹785 Cr ▼4.8% | ₹825 Cr ▼3.2% | ₹852 Cr ▼3.3% | ₹881 Cr |
| CWIP | ₹0 Cr ▼100.0% | ₹57 Cr ▼13.6% | ₹66 Cr ▼15.4% | ₹78 Cr ▼8.2% | ₹85 Cr ▼14.1% | ₹99 Cr ▼13.9% | ₹115 Cr ▲15.0% | ₹100 Cr ▲0.0% | ₹100 Cr ▼2.0% | ₹102 Cr |
| Investments | ₹1 Cr ▲0.0% | ₹1 Cr ▲0.0% | ₹1 Cr ▲0.0% | ₹1 Cr ▲0.0% | ₹1 Cr ▲0.0% | ₹1 Cr | ₹0 Cr ▼100.0% | ₹1 Cr ▲0.0% | ₹1 Cr ▲0.0% | ₹1 Cr |
| Other Assets | ₹1.8K Cr ▲31.6% | ₹1.4K Cr ▼8.4% | ₹1.5K Cr ▲2.3% | ₹1.4K Cr ▼8.4% | ₹1.6K Cr ▲4.3% | ₹1.5K Cr ▼12.5% | ₹1.7K Cr ▼2.6% | ₹1.8K Cr ▲0.5% | ₹1.8K Cr ▲10.9% | ₹1.6K Cr |
| Total Assets | ₹1.8K Cr ▼11.3% | ₹2.0K Cr ▼6.6% | ₹2.2K Cr ▲0.1% | ₹2.2K Cr ▼8.4% | ₹2.4K Cr ▲0.1% | ₹2.4K Cr ▼9.3% | ₹2.6K Cr ▼2.7% | ₹2.7K Cr ▼0.7% | ₹2.7K Cr ▲5.5% | ₹2.6K Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹169 Cr ▼24.9% | ₹225 Cr ▲67.9% | ₹134 Cr ▲41.1% | ₹95 Cr ▲352.4% | ₹21 Cr ▼92.6% | ₹285 Cr ▲19.2% | ₹239 Cr ▲267.7% | ₹65 Cr ▼67.3% | ₹199 Cr ▲17.8% | ₹169 Cr |
| Investing CF | ₹-42 Cr ▼147.1% | ₹-17 Cr ▼132.7% | ₹52 Cr ▲205.9% | ₹17 Cr ▲158.6% | ₹-29 Cr ▲12.1% | ₹-33 Cr ▼26.9% | ₹-26 Cr ▲10.3% | ₹-29 Cr ▼61.1% | ₹-18 Cr ▲76.6% | ₹-77 Cr |
| Financing CF | ₹-128 Cr ▲37.6% | ₹-205 Cr ▼10.2% | ₹-186 Cr ▼56.3% | ₹-119 Cr ▼1181.8% | ₹11 Cr ▲104.4% | ₹-252 Cr ▼25.4% | ₹-201 Cr ▼402.5% | ₹-40 Cr ▲80.4% | ₹-204 Cr ▼129.2% | ₹-89 Cr |
| Net Cash Flow | ₹-1 Cr ▼150.0% | ₹2 Cr | ₹0 Cr ▲100.0% | ₹-8 Cr ▼300.0% | ₹4 Cr | ₹0 Cr ▼100.0% | ₹12 Cr ▲400.0% | ₹-4 Cr ▲82.6% | ₹-23 Cr ▼866.7% | ₹3 Cr |
| Free Cash Flow | ₹126 Cr ▼35.4% | ₹195 Cr ▲6.6% | ₹183 Cr ▲66.4% | ₹110 Cr ▲1200.0% | ₹-10 Cr ▼104.0% | ₹249 Cr ▲22.1% | ₹204 Cr ▲537.5% | ₹32 Cr ▼81.6% | ₹174 Cr ▲100.0% | ₹87 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 76d ▼7.3% | 82d ▲22.4% | 67d ▼31.6% | 98d ▲10.1% | 89d ▲45.9% | 61d ▼16.4% | 73d ▼38.7% | 119d ▲6.3% | 112d ▲4.7% | 107d |
| Inventory Days | 184d ▼14.4% | 215d ▲1.4% | 212d ▲7.6% | 197d ▲6.5% | 185d ▼3.6% | 192d ▲27.2% | 151d ▼33.2% | 226d ▼16.3% | 270d ▲3.8% | 260d |
| Days Payable | 117d ▼7.9% | 127d ▲27.0% | 100d ▼10.7% | 112d ▲3.7% | 108d ▲3.8% | 104d ▲30.0% | 80d ▼43.7% | 142d ▼15.0% | 167d ▲8.4% | 154d |
| Cash Conv. Cycle | 143d ▼15.9% | 170d ▼5.0% | 179d ▼1.6% | 182d ▲9.6% | 166d ▲10.7% | 150d ▲3.4% | 145d ▼28.6% | 203d ▼5.6% | 215d ▲0.9% | 213d |
| Working Capital Days | 43d ▼31.7% | 63d ▼18.2% | 77d ▲5.5% | 73d ▲1116.7% | 6d ▼88.7% | 53d ▲15.2% | 46d ▼31.3% | 67d ▲48.9% | 45d ▲9.8% | 41d |
| ROCE | -5.0% ▼183.3% | 6.0% | 0.0% ▼100.0% | 5.0% ▲66.7% | 3.0% ▼62.5% | 8.0% ▼20.0% | 10.0% ▲11.1% | 9.0% ▼10.0% | 10.0% ▲0.0% | 10.0% |
Source: Screener.in · Lower days = better efficiency
Related Analysis
Frequently Asked Questions
What is Nectar Lifesciences Limited share price today?▾
Nectar Lifesciences Limited (NECLIFE) is currently trading at ₹11.98 on NSE, up 0.00% as of the last market session. Prices update daily after market close on MarketNetra.
Is Nectar Lifesciences Limited available in F&O (Futures & Options)?▾
Yes, Nectar Lifesciences Limited (NECLIFE) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Nectar Lifesciences Limited 52-week high and low?▾
Nectar Lifesciences Limited's 52-week high is ₹25.7 and the 52-week low is ₹9.2. The current price of ₹11.98 is 53.4% below the 52W high.
What is Nectar Lifesciences Limited P/E ratio?▾
Nectar Lifesciences Limited's P/E ratio and other fundamental metrics including P/B, ROE, and ROCE are available on the overview page. Data is sourced weekly from Screener.in.
How to trade Nectar Lifesciences Limited options?▾
Nectar Lifesciences Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade NECLIFE options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.